New research from the Center for Integration of Science and Industry at Bentley University found no evidence to support claims that the price reductions anticipated under the Inflation Reduction Act would decrease R&D spending or investment in innovation.
Biopharmaceutical investment in innovation persists after passage of Inflation Reduction Act
